• Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
  • Legionella pneumophila Antibody, IgM by IFA
  • Obstetric Panel
  • OVA 1, Overa (OVA1 Next Generation) Testing
  • Hematocrit/Microhematocrit
  • Mitochondrial M2 Antibody, IgG
  • GRACILE Syndrome
  • Alpha 1 Antitrypsin, Serum
  • Hepatitis D Virus (HDV) Antibody, IgM
  • Common Variable Immunodeficiency Confirmation Panel, Flow
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Isocitrate Dehydrogenase 2 (IDH2) Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Isocitrate Dehydrogenase 2 (IDH2) Mutation Analysis
Medical Test

Methodology
Access to Isocitrate Dehydrogenase 2 (IDH2) Mutation Analysis is restricted.